SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-130888
Filing Date
2016-11-01
Accepted
2016-11-01 17:12:26
Documents
59
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v451635_10q.htm 10-Q 403196
2 EXHIBIT 31.1 v451635_ex31-1.htm EX-31.1 7413
3 EXHIBIT 31.2 v451635_ex31-2.htm EX-31.2 7374
4 EXHIBIT 32.1 v451635_ex32-1.htm EX-32.1 3674
5 EXHIBIT 32.2 v451635_ex32-2.htm EX-32.2 3800
  Complete submission text file 0001144204-16-130888.txt   3805640

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyeg-20160930.xml EX-101.INS 715625
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20160930.xsd EX-101.SCH 38456
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20160930_cal.xml EX-101.CAL 43633
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20160930_def.xml EX-101.DEF 256825
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20160930_lab.xml EX-101.LAB 334291
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20160930_pre.xml EX-101.PRE 302838
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 161965575
SIC: 2834 Pharmaceutical Preparations